| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |